Anti epidemic stocks rose collectively, and a number of covid-19 vaccines were intensively approved for clinical trials

Anti epidemic stocks rose collectively, with Geli pharma-b up 17%, Kaifa pharma-b up 15%, Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) , good doctor Ping’an up 7%, Cansino Biologics Inc(688185) bio-b and stone pharmaceutical group up 6%, Ali health up 5%, tengshengbo pharma-b up 4% and China Bio up 2%. On the news, from the 3rd to the 4th of this month, three domestic covid-19 vaccines of Cansino Biologics Inc(688185) biology, Sinopharm China biology and Shijiazhuang Pharmaceutical Group were successively approved by the State Drug Administration to carry out clinical trials.